Bavarian Nordic Signs Up US Firm for Packaging Monkeypox Vaccine

An employee of the vaccine company Bavarian Nordic shows a picture of a vaccine virus on a display in a laboratory of the company in Martinsried near Munich, Germany, on May 24, 2022. Lukas Barth
/Reuters

Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manufacturer to package its Jynneos monkeypox vaccine and the production is expected to begin later this year.

The company aims to finish the technology transfer in three months to Michigan-based Grand River Aseptic.